A 19-year-old severe thalassemia patient has recently become China's first successful case cured through cell and gene therapy at Nansha Hospital of Guangzhou First Municipal People's Hospital. This achievement marks the completion of the nation's pioneering clinical application for transfusion-dependent β-thalassemia, resulting in a definitive cure.

Dr. Huang Jinqi, Deputy Director of Hematology at the hospital, emphasized that severe thalassemia—an inherited hemolytic disorder—historically cut life expectancy to under 20 years without treatment, while conventional therapies remained costly and hazardous.

Source: GDToday
Editor: Wu Di